Proactive Investors - Run By Investors For Investors

Live Company shares rise as touring subsidiary clinches lease deal for Mythical Beasts models

The agreement will involve the leasing of 50 LEGO statues built by Bright Bricks, the world’s largest LEGO statue builder which was acquired by LVCG in October
Lego Chimera statue
One of the 50 models is a statue of the three-headed Chimera

Live Company Group Plc’s (LON:LVCG) shares were lifted in early trading Friday after its touring subsidiary, Bricklive Touring Limited (BTL), inked a lease agreement with a South Korean firm for its Mythical Beasts touring assets.

The media group, which runs events involving LEGO statues under its BRICKLIVE brand, said the agreement between BTL and AWC Asia would run until December 2021 and involve the lease of 50 models created and built by Bright Bricks, the world’s largest LEGO statue builder which was acquired by LVCG in October.

READ: Live Company Group unveils BRICKLIVE BRICKOSAURS touring show

In return for the lease, AWC will pay BLT a content and license fee of US$1.3mln in cash up front, with the tour scheduled to launch in South Korea at the end of January 2019.

David Ciclitira, executive chairman of Live Company, said the deal was the “first example” of the opportunities offered by its acquisition of Bright Bricks, adding that the assets were “a complementary fit to our existing network”.

The news comes as the company prepares to launch its own tour, BRICKLIVE BRICKOSAURS, in April next year at the Marwell Zoo near Southampton.

Shares were up 1.5% at 68p.

--Adds share price--

View full LVCG profile View Profile

Live Company Group Plc Timeline

Related Articles

Live Company
March 05 2019
Since listing on AIM in December 2017, the company has been pursuing an aggressive strategy of expansion and brand building that has paid off for the share price.
March 04 2019
At the Completion Contract business there have been lower volumes and the average budget per film has reduced
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use